Skip to Main Content

Paper Details

Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.
Neuro Oncol
110
2019
Meningioma, meningioma, meningiomas, patients
Author NameAffiliation
Raymond Y HuangBrigham and Women's Hospital
Wenya Linda BiCenter for Skull Base and Pituitary Surgery, Brigham and Women's Hospital
Michael WellerUniversity Hospital Zurich
Thomas J KaleyMemorial Sloan Kettering Cancer Center
Jaishri O BlakeleyThe Johns Hopkins Hospital
Ian F DunnCenter for Skull Base and Pituitary Surgery, Brigham and Women's Hospital
Matthias PreusserClinical Division of Oncology, Comprehensive Cancer Centre, Medical University Vienna-General Hospital
Matthias PreusserClinical Division of Oncology, Comprehensive Cancer Centre, Medical University Vienna-General Hospital
Michael W McDermottUniversity of California San Francisco
Michael W McDermottUniversity of California San Francisco
C Leland RogersBarrow Neurological Institute
David SchiffUniversity of Virginia
Michael A VogelbaumRose Ella Burkhardt Brain Tumor and Neuro Oncology Center, Cleveland Clinic
Patrick Y WenDana-Farber/Brigham and Women's Cancer Center
  • 1 - 14

Datasets